Company Comparison
Editas Medicine vs BioAnalytics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Editas Medicine | BioAnalytics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | located in Cambridge, Massachusetts | Boston |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $55M |
| Valuation | — | — |
What They Build
Editas Medicine
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology.
BioAnalytics
Boston-based biotech company developing analytics and data solutions for the life sciences industry.
Key Investors
Editas Medicine
BioAnalytics
No investors listed.
Sector Overlap
Both Editas Medicine and BioAnalytics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.